Market Cap (In INR)
197.79 Million
Revenue (In INR)
271.24 Million
Net Income (In INR)
7.68 Million
Avg. Volume
2955.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.47-40.0
- PE
- -
- EPS
- -
- Beta Value
- 1.2809423
- ISIN
- INE415H01017
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sanjay B. Sethi
- Employee Count
- -
- Website
- http://www.beryldrugs.com
- Ipo Date
- 2005-06-14
- Details
- Beryl Drugs Ltd. engages in the manufacture of bulk drugs. It offers small volume injectables in liquid and dry form, eye and ear drops, Intravenous fluids in polypack and glass bottles and veterinary medicines. The company was founded on August 24, 1993 and is headquartered in Indore, India.
More Stocks
-
XCFKTMG Limited
XCF
-
AHRO
-
SNTWSummit Networks Inc.
SNTW
-
FBSI
-
LPE
-
ESEN
-
SHRDAISSharda Ispat Limited
SHRDAIS
-
FLMP